Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-058147

COO and Secretary sold 15,000 shares at an average $18.02 ($270,287)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2019-11-22 Sale −646 $18.00 $11,628 598,732 I
Schuth Alexander O. COO and Secretary 2019-11-25 Sale −14,125 $18.02 $254,533 584,607 I
Schuth Alexander O. COO and Secretary 2019-11-26 Sale −229 $18.02 $4,127 584,378 I
Open-market sales · 15,000 sh · avg $18.02 · $270,287
Loading xslF345X03/doc4.xml…